Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Public ClinicalTrials.gov record NCT07529808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1/2, Open-Label, Multicenter, Dose Escalation and Expansion Study of BHB810 in Participants With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Study identification
- NCT ID
- NCT07529808
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- BigHat Biosciences, Inc.
- Industry
- Enrollment
- 164 participants
Conditions and interventions
Conditions
- Gastric Cancer
- Gastric Adenocarcinoma
- Gastric (Stomach) Cancer
- Gastroesophageal Adenocarcinoma
- Gastroesophageal Cancer (GC)
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastroesophageal Junction (GEJ) Cancer
- Gastrointestinal Cancer Metastatic
- Gastrointestinal Adenocarcinoma
- Gastrointestinal Cancers
- Colorectal (Colon or Rectal) Cancer
- Pancreatic Cancer
- CDH17-positive Advanced Solid Tumors
- Advanced Gastric Cancer
Interventions
- BHB810 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2026
- Primary completion
- Nov 30, 2028
- Completion
- Nov 30, 2028
- Last update posted
- Jul 7, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NEXT Virginia | Fairfax | Virginia | 22031 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07529808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07529808 live on ClinicalTrials.gov.